DT
Diversified Trust Portfolio holdings
AUM
$4.51B
This Quarter Return
-3.67%
1 Year Return
+15.61%
3 Year Return
+65.44%
5 Year Return
+102.62%
10 Year Return
+175.01%
AUM
$2.86B
AUM Growth
+$2.86B
(-5.7%)
Cap. Flow
+$18.3M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
50.83%
Holding
926
New
95
Increased
336
Reduced
241
Closed
129
Top Buys
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
$12.8M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
$9.98M |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$8.38M |
| 4 |
DexCom
DXCM
|
$4.29M |
| 5 |
UnitedHealth
UNH
|
$4.13M |
Top Sells
| 1 |
Netflix
NFLX
|
$5.95M |
| 2 |
Citigroup
C
|
$5.68M |
| 3 |
Norfolk Southern
NSC
|
$4.46M |
| 4 |
Chubb
CB
|
$4.05M |
| 5 |
Public Storage
PSA
|
$4.03M |
Sector Composition
| 1 | Technology | 9.13% |
| 2 | Healthcare | 6.76% |
| 3 | Consumer Staples | 5.95% |
| 4 | Financials | 5.82% |
| 5 | Consumer Discretionary | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
DTE Energy
DTE
$28.4B
| $2.12M | 0.07% | 16,047 | – | – |
|
127
Gilead Sciences
GILD
$140B
| $2.11M | 0.07% | 35,529 +1,982 | +6% | +$118K |
|
128
Target
TGT
$43.6B
| $2.06M | 0.07% | 9,704 -504 | -5% | -$107K |
|
129
Synopsys
SNPS
$112B
| $2.05M | 0.07% | 6,161 +1,331 | +28% | +$444K |
|
130
Palo Alto Networks
PANW
$127B
| $2.03M | 0.07% | 3,256 -150 | -4% | -$93.4K |
|
131
ASE Group
ASX
$21.6B
| $2.01M | 0.07% | 283,116 | – | – |
|
132
Everest Group
EG
$14.3B
| $2.01M | 0.07% | 6,654 +1,603 | +32% | +$483K |
|
133
Martin Marietta Materials
MLM
$37.2B
| $2M | 0.07% | 5,200 | – | – |
|
134
RTX Corp
RTX
$212B
| $1.94M | 0.07% | 19,547 -1,112 | -5% | -$110K |
|
135
Salesforce
CRM
$245B
| $1.93M | 0.07% | 9,087 -1,940 | -18% | -$412K |
|
136
McKesson
MCK
$85.4B
| $1.9M | 0.07% | 6,212 | – | – |
|
137
CONMED
CNMD
$1.68B
| $1.89M | 0.07% | 12,752 +177 | +1% | +$26.3K |
|
138
Integra LifeSciences
IART
$1.18B
| $1.87M | 0.07% | 29,036 +2,425 | +9% | +$156K |
|
139
Bio-Rad Laboratories Class A
BIO
$8.06B
| $1.84M | 0.06% | 3,273 +859 | +36% | +$484K |
|
140
Ovintiv
OVV
$10.8B
| $1.84M | 0.06% | 34,031 +286 | +0.8% | +$15.5K |
|
141
Oracle
ORCL
$635B
| $1.82M | 0.06% | 22,036 -949 | -4% | -$78.5K |
|
142
Bristol-Myers Squibb
BMY
$96B
| $1.81M | 0.06% | 24,782 +8,975 | +57% | +$656K |
|
143
Veeva Systems
VEEV
$44B
| $1.8M | 0.06% | 8,492 +3,124 | +58% | +$664K |
|
144
IBM
IBM
$227B
| $1.8M | 0.06% | 13,867 -802 | -5% | -$104K |
|
145
iShares MSCI USA Quality Factor ETF
QUAL
$54.2B
| $1.8M | 0.06% | 13,373 -1,936 | -13% | -$261K |
|
146
Thermo Fisher Scientific
TMO
$186B
| $1.79M | 0.06% | 3,024 -777 | -20% | -$459K |
|
147
iShares ESG Aware MSCI EAFE ETF
ESGD
$9.89B
| $1.78M | 0.06% | 24,085 -320 | -1% | -$23.6K |
|
148
Caterpillar
CAT
$196B
| $1.77M | 0.06% | 7,925 -2,035 | -20% | -$453K |
|
149
Arthur J. Gallagher & Co
AJG
$77.6B
| $1.76M | 0.06% | 10,099 +477 | +5% | +$83.3K |
|
150
Advanced Micro Devices
AMD
$264B
| $1.75M | 0.06% | 16,011 +4,583 | +40% | +$501K |
|